Litigation Details for ABRAXIS BIOSCIENCE, LLC v. CIPLA LTD. (D.N.J. 2016)

✉ Email this page to a colleague

Docket	⤷ Try a Trial	Date Filed	2016-12-06
Court	District Court, D. New Jersey	Date Terminated	2018-10-09
Cause	15:1126 Patent Infringement	Assigned To	John Michael Vazquez
Jury Demand	None	Referred To	Mark Falk
Parties	ABRAXIS BIOSCIENCE, LLC
Patents	6,096,331; 6,179,817; 6,197,051; 6,506,405; 6,537,579; 6,565,842; 6,749,868; 6,753,006; 7,820,788; 7,923,536; 8,138,229; 8,257,733; 8,268,348; 8,314,156; 8,853,260
Attorneys	CATHERINE THISBE MATTES
Firms	Kilpatrick Townsend & Stockton LLP
Link to Docket	External link to docket

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2016-12-06	1		This patent is subject to a terminal dis- 6,096,331 A 8/2000 …than about 1 micron. The use of speci?c 6,096,331. …2011/0118342 A1 5/2011 D6 6t 31. 6,096,331 A 8/2000 Desai et 3L …7,923,536 (the “’536 patent”), 8,138,229 (the “’229 patent”), and 8,853,260 (the “’260 patent”), all owned … 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C	External link to document
2018-10-09	123		Judgment, the term “Patents-in-Suit” shall mean U.S. Patent Nos. 7,$20,78$, 7.923,536, $,13$,229, and … 4. Until expiration of the Patents-in-Suit. Cipla, including any of its successors…successors and assigns, is enjoined from infringing the Patents-in-Suit, on its own part or through Case 2:16-cv…parties in connection with any infringement of the Patents-in-Suit by any such third parties. cinless and…C.F.R. § 314.94(a)(12) with respect to the Patents-in-Suit. 9. Nothing herein	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document